New Kidney Disease Therapies Strike at the Root of IgA Nephropathy
A new review maps how mechanism-based therapies targeting galactose-deficient IgA1 are transforming IgA nephropathy treatment, from mucosal interventions to APRIL ...
A new review maps how mechanism-based therapies targeting galactose-deficient IgA1 are transforming IgA nephropathy treatment, from mucosal interventions to APRIL ...
A synthetic antimicrobial peptide called SK1217 suppressed autoantibodies, cytokines, BAFF-driven B cell activation, and kidney damage in a pristane-induced lupus ...
A computational reverse vaccinology study has designed BAFF- and APRIL-adjuvanted multi-epitope vaccine candidates against human metapneumovirus, a major respiratory pathogen ...
A phase III trial of obinutuzumab β shows striking efficacy in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder, deepening questions about which ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine